{"name":"Theramex","slug":"theramex","ticker":"","exchange":"","domain":"theramex.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQNm8zcllXUmdxSGtBRU5saGFGVWFrckFWaGNzaFBic3Jod3U3b2dWOFJTbmNjUGNCTTZMNnZxZXE0MFNFd2lkZ2NjNGdPYUdJQ1ZNOENpZ2thck1BdExTdkNtUWg0dnhIRl9hQmVwalpUaTB6SDNFTG1aT1hOYm1pZ1J1QnZBNkFGZUxkeHhTcE9hNXJ3V1I1MWdGMDBTeFd1TG8tcDhUUVJzdTlYQTYzX0RMV3ZpQQ?oc=5","date":"2025-07-22","type":"pipeline","source":"Fierce Pharma","summary":"UK marketing watchdog slams Theramex for 'wholly unacceptable' compliance failings - Fierce Pharma","headline":"UK marketing watchdog slams Theramex for 'wholly unacceptable' compliance failings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNaTdHYkg3aG03blVWRnV3RllhNTAtWWtjNnAzY3hWalJheTdLZEZDMUw1MTE2dVFTdG5CaGh5RGhxZExOaXJkamh4U0dLcnFobUJCZWlZUEtQZzYtdFZDdHUzM2hPWXZtbEpiUlhJN1N2ZlJmZnREWXVNc2JwQzdJTUoyMTdSZndFb1N1Z3NVVE5QUEk0VEc1bw?oc=5","date":"2025-07-21","type":"pipeline","source":"The Independent","summary":"Major HRT supplier sanctioned after whistleblowers raise concerns over patient safety - The Independent","headline":"Major HRT supplier sanctioned after whistleblowers raise concerns over patient safety","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPc3FLaUl6WkdUbWJaY1VRelBIZTFoR2MtdWFzYVpnZG9zcjdOVm1RaHNCdm9QUUtPanhDa3g1dThoUnhWMk5HWUdSdkdsQ0lrdGJ3eUJTWWJEaG5iUEs2Q3pjdWVOVDh0RjEzbmlGckc2M21HbVVpNW1GWE0zRnhCZkh4dXNyb2tBVnItVDQxTWJya2FVczd5UVE4SEhMVngtQkMtQTZvcl95Q0c3cVp6QnRVVy1uMkRrOXRqMklRMWY0bDY2amlnZGNXcU8yNFF1WVE?oc=5","date":"2024-11-22","type":"pipeline","source":"Reuters","summary":"UK watchdog fines Viatris $1.9 mln over rule breach in Theramex probe - Reuters","headline":"UK watchdog fines Viatris $1.9 mln over rule breach in Theramex probe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOaTFCSFhVeVNZdEpBendBZ2RJRHM2amNISXpySmhNVldRdDBpRXdIM2NtdEluUlhBeXVFYW1XeWh1aG9VbXRBTHZIQVk3UHVSVHpBdE5WMFFoMjdrT190RHBDVDJ0Z0IzMjU3UDZ2eVNKUlZnWW1Ud1B3QUhOSnlhb1pkdDI2UzlqM1pSdU1Dek1fMWFDZGctQU9fMmVmUmN0N2Fn?oc=5","date":"2024-08-20","type":"pipeline","source":"PharmaTimes","summary":"Theramex’s Eladynos recommended by NICE for post-menopausal bone disease - PharmaTimes","headline":"Theramex’s Eladynos recommended by NICE for post-menopausal bone disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPRXQtekF3eklpdVpVandFa1ZSX2NGaVVNRFF1eTlockN6eGM3Mm5RV2FuOFZZSWNyRmplanJvdU13cFBKR3E5VExqOERJTEtCZXNzckowY241ZFpfUGpFLUszaXoydEZYRVowMVllbWJvclUtV2JoaHlhVmo0MGhuQXBuM2ctemNhd2c?oc=5","date":"2024-08-15","type":"pipeline","source":"pharmaphorum","summary":"Theramex's uterine fibroid drug Yselty backed for NHS use - pharmaphorum","headline":"Theramex's uterine fibroid drug Yselty backed for NHS use","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNYXh0a1NTNEZUQ2hWRDlsSWxZNWhocHJ1WDUzTXhCaDVEa0xrZnpWMm1nVGh3dHFwRUliLVlaUEJTa1J0YUN1d2ZkZzlUR1VIZmZ2TVQ5NFNJRDNDQ1Z1b01fU0VZakttR1ZwV3hiQUpVdVNaZEo1U1ptUE1NY0I4UGM5QzExN3pfU1VFVzByTVFzYTVUQ1Q1ZkJzTF9oVTJGRlhfZGxvUkMyYk9ybzY0Yg?oc=5","date":"2024-08-09","type":"pipeline","source":"Pharmaceutical Technology","summary":"NICE supports Theramex’s Eladynos for post-menopause osteoporosis - Pharmaceutical Technology","headline":"NICE supports Theramex’s Eladynos for post-menopause osteoporosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPZTczeGszNHQ4djY0R1FaOUkwMlE5cnF4bmItaFVWUWNNODNVTFZ0RWxfRm9tbTNEQ1Y5alhLNU1sREFQaWRzRjhVZDJtTmMxZVk5QWRXRzhGdGtoNWJFWkRackp4UG9OVGczQmNpM3Zkb1VabHVnWUxJZkpJc2RzYURjNU5sazhMMHM4OHlrY3R1ZVpGNHhyQ2duVkw4RTVsQUFwNjczZFlteDluT3ZuelZlSVgxWXFqeW1FSTlMdEhpZmxJYWw4RHJHenhYTFFTb3M3UmhhcnF6NkJwLUluV2VrWk1xMy11YXRteExHMkY0d3dvSUxxRTJKVDBNdUU?oc=5","date":"2023-05-22","type":"pipeline","source":"Taylor Wessing","summary":"Theramex enters into an exclusive licensing agreement with Radius Health Inc to commercialise ELADYNOS® - Taylor Wessing","headline":"Theramex enters into an exclusive licensing agreement with Radius Health Inc to commercialise ELADYNOS®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPR3FWV0dpbkl3dE1yellIOGREUlRpMWUwMW5ScUo0NVRSRXNwVWQ2WmczaDFoaUU4UVdVV0x3NTJrV3FJTWo2RzlxMEZTaWVQWXpWUE1EdXdXTXRUSzFWRXZDZGJfTGNZUUpCTVQzNGNjaXFqaHZKMUFGaTZqVUlyaWp5MmVXcXl0N1dOZHRsSTFfWjhvN0k0RkJLOWhkT2VwMlI0d0l3?oc=5","date":"2022-03-28","type":"deal","source":"The Pharma Letter","summary":"Carlyle and PAI Partners to acquire Theramex from CVC Funds - The Pharma Letter","headline":"Carlyle and PAI Partners to acquire Theramex from CVC Funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOaVJORFhZazBISnJ2R2J5bXNYX2JFVy1yWFh1V3h6MVNnNV9FOWVhQVZSdHFvMHRQbEVGUUVSYzR5LXY3M1pobEd4Qi1NendJa1J1Y0FCWkZ5elFEWGw0c19CeWx1UE1Hb01tYVJuS3oxcnh0YmRrZzlGLVdVX2V5Mjh1cWgxcXVnTEZMZVFlMXVHVzBudnBmNk5B0gGfAUFVX3lxTFB6d05FTTF2eGllS2JUX29qMjRKRGl3Y2o5ZnhyTHZvV2tqMWxKTGhUd3dxNE14eC1EbDd6OXFpZEd2U1VhbEtXU0diY2Q4d0E4TE53Vms3R2puV2pVUFNxMzZBeXhka2l2TEg0ZmxRZjQ2Vl9Tei04ZGttUFMxZkxTemQ1aHVjd1ljYlF1SThIUGRnLWh6T2o5NlQyWDEyOA?oc=5","date":"2022-03-28","type":"deal","source":"Private Equity News","summary":"PAI and Carlyle buy £1.2bn women’s pharma firm from CVC - Private Equity News","headline":"PAI and Carlyle buy £1.2bn women’s pharma firm from CVC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPVEtFaEFzZXA2cGtQNFdZZEdnREo4S1FOVFhEdzZUUlZLUDN2b3JNNjFCc1J1Vk1URlZNUEloVE4tbVNSc1dsSGlxbmhXbWdkSkRhT0dPWEFYS3hqb1hHbm9QWnB4Q2tSRlAyV3B1RV9TVVdOS3NWVjh4VFI5X3J5eFRPbVpqZUFCVlFseE5hcmlKMHQ1Y3FmYVBfNC1RbzIwQjNTTnJPZkR1WUlfYlp4c0pMa0xkY2hGOEw5UWt3LWstM0tVTDdINHY5N2ZBN2dNNWxyYUxtUktHeXBjSmd5NldQRHoxbnZONWNLTVZoSGVaVk9kXzRF?oc=5","date":"2022-02-10","type":"pipeline","source":"GlobeNewswire","summary":"ObsEva Enters into Licensing Agreement with Theramex for the Commercialization of Linzagolix - GlobeNewswire","headline":"ObsEva Enters into Licensing Agreement with Theramex for the Commercialization of Linzagolix","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNd01hMHFWV2g3UGRmZGtIbmN6X3g1Zi1RRmZnSFRrNXdaTThwUFJ0ZVFwcUVrV3RBYmIwdzBVUXNPMW03WHB1YWNLMUdMRnlkeExXdW1rUVRHSXllWS02eUV6d1ZKVFBtWXo5Y1duV2trc3MzbFlvMHZyRHRMQllJNmt1QlloUW5aNktaazE5SHJkT1RPZ3JvazIxQUh1ZmpI?oc=5","date":"2021-06-25","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Theramex to market Prolia biosimilar in Europe and Australia - Generics and Biosimilars Initiative","headline":"Theramex to market Prolia biosimilar in Europe and Australia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOUkEtejZUMEhCa1Z5Ynd0aXJhU1E3VmFVVUhIZWpIRFRQMU9TWFhlU0FDbHRDa0x3bHhyY3BIVGxfUV9iYmliVHFzZkNENVEwd1BOcWRhdVZKd3dfYTdOUTVzRFJ2YldHdGxieEpaMzJ1WWIyTWZiY0ROaWRSWnM0c2dlVjJMUzA?oc=5","date":"2021-01-18","type":"pipeline","source":"Pharmafile","summary":"Theramex launches osteoporosis drug Livogiva in Europe - Pharmafile","headline":"Theramex launches osteoporosis drug Livogiva in Europe","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}